Madrigal: Q4 Earnings Snapshot

Audio By Carbonatix

WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Thursday reported a loss of $85.9 million in its fourth quarter.

The West Conshohocken, Pennsylvania-based company said it had a loss of $4.98 per share.

The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $4.41 per share.

For the year, the company reported that its loss widened to $295.4 million, or $17.23 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL